Evidence map›Paper›PMID 38214078›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2024

Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023.

Cheng Gong, Fang Huang, Luodan Suo, Xuejiao Guan, Lu Kang, Hui Xie, Geng Hu, Peng Yang, Quanyi Wang

Open access · diamondAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
27.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Host inflammatory markers and MLVA profiling for risk assessment of severe pediatricFrontiers in cellular and infection microbiology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Characterizing the epidemiology ofEmerging microbes & infections · 2025
    Article
  19. Article
  20. Development and validation of a multi-platform LAMP system for rapid HAdV-3 and HAdV-7 detection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Cheng GongBeijing Center for Disease Prevention and Control, Beijing, People's Republic of China.
Fang HuangBeijing Center for Disease Prevention and Control, Beijing, People's Republic of China.
Luodan SuoBeijing Center for Disease Prevention and Control, Beijing, People's Republic of China.
Xuejiao GuanBeijing Center for Disease Prevention and Control, Beijing, People's Republic of China.
Lu KangBeijing Center for Disease Prevention and Control, Beijing, People's Republic of China.
Hui XieBeijing Center for Disease Prevention and Control, Beijing, People's Republic of China.
Geng HuBeijing Center for Disease Prevention and Control, Beijing, People's Republic of China.
Peng YangBeijing Center for Disease Prevention and Control, Beijing, People's Republic of China.
Quanyi WangBeijing Center for Disease Prevention and Control, Beijing, People's Republic of China.
Beijing Center for Disease Prevention and Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2023, through an ongoing respiratory pathogen surveillance system, we observed from mid-September onwards, an increase of respiratory illness among children aged ≤ 15 years presenting at hospital outpatient clinics in Beijing, China. Data indicated that illness was caused by multiple pathogens, predominantly

Indexed as

Pneumonia, MycoplasmaAnti-Bacterial AgentsBeijingChildChinaDrug Resistance, BacterialHumansMacrolidesMycoplasma pneumoniaeAnti-Bacterial AgentsMacrolidesMycoplasma pneumoniaepediatric pneumoniarespiratory illnessseasonalitysurveillance

Identifiers

PMID38214078
PMCPMC10785205
OpenAlexW4390791895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.